MREO
Mereo BioPharma Group plc
MREO • NASDAQ
Mereo BioPharma Group plc is a pharmaceutical preparations company trading on NASDAQ, led by CEO Denise Vera Scots-Knight.
CEODenise Vera Scots-Knight
Next Earnings
Upcoming earnings announcement for Mereo BioPharma Group plc
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.02
Revenue Estimate
$16.6M
Earnings History
Past 12 earnings reports for Mereo BioPharma Group plc
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.01Est: -$0.01 | 0.0% | -Est: $5.3M | -100.0% |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.01Est: -$0.01 | 0.0% | -Est: $16.2M | -100.0% | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.02Est: -$0.01 | -100.0% | $500.0K | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.02Est: -$0.01 | -100.0% | -Est: $11.9M | -100.0% | 10-Q |
| Mar 26, 2025 | Q4 2024 | -$0.01 | — | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.02Est: -$0.02 | 0.0% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.02 | — | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.01 | — | - | — | 10-Q |
| Mar 27, 2024 | FY 2023 | -$0.04 | — | $10.0M | — | 10-K |
| Sep 7, 2023 | H1 2022 | -$0.03 | — | $8.8M | — | — |
| Mar 31, 2022 | FY 2022 | -$0.07 | — | $50.2M | — | — |
| Nov 8, 2021 | H1 2021 | $0.00 | — | $50.6M | — | — |